Showing results (1261-1270 of 1,376) with videos related to
Sort By:
Pageof 138
Neuro-Oncology Advances|May 5, 2025
Nuclear NAD+ synthase nicotinamide mononucleotide adenylyltransferase 1 contributes to nuclear atypia and promotes glioma growthJiaqi Liu, Yi Zhu, Tijana Canic, et al.Neuro-Oncology Advances|April 25, 2025
Expedited chemoradiation after laser interstitial thermal therapy (LITT) is feasible and safe in patients with newly diagnosed glioblastomaJennifer S Yu, Seth M Meade, Ran Zhao, et al.Neuro-Oncology Advances|October 17, 2025
Label-free fluorescence lifetime imaging for real-time guidance of stereotactic biopsy: A feasibility study in brain cancer patientsAlba Alfonso-Garcia, Julien Bec, Mohamed Abul Hassan, et al.Neuro-Oncology Advances|October 22, 2025
Challenges in diagnostics and treatment of infant-type hemispheric gliomasLudmila Papusha, Margarita Zaytseva, Maria Senchenko, et al.Neuro-Oncology Advances|September 29, 2025
Changes in functional connectivity are associated with functional independence in the early postoperative period following awake surgical resection of language-eloquent gliomaKyle R Noll, Evan D Bander, Henry S Chen, et al.Neuro-Oncology Advances|September 11, 2025
Biomarkers of immunotherapy response in neuro-oncologyAlexander P Landry, Yosef Ellenbogen, Andrew Ajisebutu, et al.Neuro-Oncology Advances|February 16, 2026
Biostatistical benchmarking of neuro-oncology trialsRahim Abo Kasem, Lydia A Leavitt, Gina Genova, et al.Neuro-Oncology Advances|November 16, 2022
Prediagnostic biomarkers for early detection of glioma-using case-control studies from cohorts as study approachWendy Yi-Ying Wu, Anna M Dahlin, Carl Wibom, et al.Neuro-Oncology Advances|November 16, 2022
Clinical utility of plasma cell-free DNA in gliomasErica L Carpenter, Stephen J BagleyPageof 138